November 18, 2026
Health news, explained with evidence
LIVE
Preventive Services Task Force Resumes Meetings Under New Leadership Blood-Based Genetic Signature May Predict CAR T-Cell Therapy Success in Lymphoma Ultraprocessed Diets May Impact Brain Reward Systems in Younger Adults Addressing Body Image and the Reality of Gluteal Anatomy Migraine and Smoking Linked to Increased Early Stroke Risk in Women CBD Oil Found Ineffective for Managing Behavioral Issues in Youths with Intellectual Disabilities Expert Advice on Hydration Gear Sparks Debate Among Recreational Runners A Structured Approach to Beginning a Strength and Cardio Routine The Role of Daily Mobility Training in Managing Sedentary Tension New Theoretical Framework Explores Memory Formation and Dementia Preventive Services Task Force Resumes Meetings Under New Leadership Blood-Based Genetic Signature May Predict CAR T-Cell Therapy Success in Lymphoma Ultraprocessed Diets May Impact Brain Reward Systems in Younger Adults Addressing Body Image and the Reality of Gluteal Anatomy Migraine and Smoking Linked to Increased Early Stroke Risk in Women CBD Oil Found Ineffective for Managing Behavioral Issues in Youths with Intellectual Disabilities Expert Advice on Hydration Gear Sparks Debate Among Recreational Runners A Structured Approach to Beginning a Strength and Cardio Routine The Role of Daily Mobility Training in Managing Sedentary Tension New Theoretical Framework Explores Memory Formation and Dementia

Semaglutide-Treated Stem Cells Reduce Jaw Bone Loss in Animal Study

🥗 Nutrition 1 min read 👁 4

Researchers found that semaglutide promotes bone cell growth and reduces fat accumulation in rat stem cells, shedding light on potential mechanisms for bone health.

🥗Nutrition

Key points

  • Laboratory study showed semaglutide-treated stem cells helped reduce jaw bone loss in rats.
  • Researchers identified a molecular pathway that encourages stem cells to form bone rather than fat.
  • Findings are based on animal models and require human clinical studies to confirm effectiveness.

Researchers at Hebei Medical University and the Key Orthopaedic Biomechanics Laboratory of Hebei Province in China investigated how the metabolic drug semaglutide influences bone health in animal models. In a study published in Nature Health Sciences, the team demonstrated that jaw bone marrow mesenchymal stem cells treated with semaglutide helped reduce jaw bone loss in rats by encouraging bone cell formation and restricting fat accumulation.

Using rat tissue cultures, advanced CT imaging, and genetic analysis, the researchers mapped the underlying cellular mechanism. They found that semaglutide activates GLP-1 receptors in jaw stem cells, initiating a molecular signaling cascade involving PKA, STAT3, TET3, SHP2, and beta-catenin. This process directs stem cells to transform into bone-building osteoblasts rather than fat cells, leading to measurable structural improvements in the jaw bones of treated rats.

What to know: This research represents early-stage laboratory testing conducted exclusively on rat cells and animal models. Because human bone tissue may respond differently, these findings do not prove that semaglutide treats human bone density disorders. Individuals should always consult a medical doctor for personalized advice regarding bone health and prescription medications.

Source Nature Health Sciences — nature.com/articles/s41598-026-78814-6 ↗

Contact the newsroom

Got a tip, a proposal or a partnership question? Write to us and we will reply shortly.